ESRRA and breast carcinoma: In the present study, SHTM2 overexpression exerted opposing effects to those of the ERRα knockdown on the cell proliferation, cell migration, ROS production and the ratio of GSH/GSSG in resistant breast cancer cells upon lapatinib treatment.